Research ArticleHuman Studies
Hypoxia in Human Gliomas: Demonstration by PET with Fluorine-18-Fluoromisonidazole
Peter E. Valk, Chester A. Mathis, Michael D. Prados, John C. Gilbert and Thomas F. Budinger
Journal of Nuclear Medicine December 1992, 33 (12) 2133-2137;
Peter E. Valk
Chester A. Mathis
Michael D. Prados
John C. Gilbert


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Hypoxia in Human Gliomas: Demonstration by PET with Fluorine-18-Fluoromisonidazole
Peter E. Valk, Chester A. Mathis, Michael D. Prados, John C. Gilbert, Thomas F. Budinger
Journal of Nuclear Medicine Dec 1992, 33 (12) 2133-2137;
Jump to section
Related Articles
- No related articles found.
Cited By...
- 18F-Fluoromisonidazole PET/CT: A Potential Tool for Predicting Primary Endocrine Therapy Resistance in Breast Cancer
- Image-Guided PO2 Probe Measurements Correlated with Parametric Images Derived from 18F-Fluoromisonidazole Small-Animal PET Data in Rats
- Impact of 3,4-Dihydroxy-6-18F-Fluoro-L-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
- Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications
- Imaging hypoxia in gliomas
- Multimodality Assessment of Brain Tumors and Tumor Recurrence
- Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
- Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape
- Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET
- Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer
- Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas
- Molecular Imaging of Metastatic Potential
- Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke
- Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival
- Positron Emission Tomography As an Imaging Biomarker
- A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density
- Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in Gliomas Using 18F-Fluoromisonidazole, 18F-FDG PET, and Immunohistochemical Studies
- Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors
- Assessment of Hypoxia and Perfusion in Human Brain Tumors Using PET with 18F-Fluoromisonidazole and 15O-H2O
- Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [18F]Fluoromisonidazole and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging